Fertility preservation is worth discussing as soon as you learn that cancer treatment could affect your ovaries. Egg or embryo freezing stores reproductive material for possible future use; ovarian tissue freezing can be an option when time is very short or a patient has not reached puberty. Ovarian-suppression medicines may help protect ovarian function during chemotherapy, but they do not replace freezing eggs, embryos or tissue. A fertility specialist can help you compare options while your cancer team keeps treatment on schedule.
How Fertility Preservation Options Differ
Egg freezing involves stimulating the ovaries, collecting mature eggs and freezing them unfertilized. It may suit you if you do not want to use sperm now or prefer to make decisions about fertilization later. Embryo freezing uses a similar process, but eggs are fertilized before freezing. It requires sperm from a partner or donor and may mean making decisions about the use of stored embryos in the future.
Both options usually require ovarian stimulation and a procedure to collect eggs. A 2022 systematic review of research on egg and embryo freezing before potentially fertility-affecting treatment concluded that, for most patients, a cycle can be completed in about two weeks. Some protocols can start at different points in the menstrual cycle. That is a common timeframe, not a promise: your health, clinic access and treatment deadline matter. In breast cancer, stimulation protocols using medicines such as letrozole can limit estrogen exposure; ask your oncology and fertility teams whether this approach fits your situation.
Ovarian tissue cryopreservation involves surgery to remove and freeze ovarian tissue, which may later be returned to the body. It does not require ovarian stimulation and can be considered when treatment needs to start quickly or for prepubertal patients. It is not suitable for everyone: the risk that tissue contains cancer cells needs careful assessment, and availability and practice vary by location. Ask what the procedure involves, whether it is appropriate for your cancer type and what would happen to the tissue later.
Ovarian-suppression medicines, often called GnRH agonists, temporarily reduce ovarian activity during chemotherapy. A 2026 narrative review of systematic reviews and meta-analyses in young women with breast cancer found these medicines were associated with better ovarian-function recovery and fewer cases of premature ovarian insufficiency. They are an additional strategy, not a way to store eggs or embryos, and cannot guarantee that fertility will be preserved. Those findings concern breast cancer; they should not automatically be assumed to apply to every cancer or treatment.
How Age, Treatment And Time Shape The Choice
The risk to fertility depends on the treatment plan, not just the cancer diagnosis. Some chemotherapy drugs, including alkylating agents, can damage ovarian reserve. Radiation involving the pelvis and surgery affecting the ovaries can also matter. Ask your oncologist which specific treatments are planned and what is known about their effects on ovarian function. The risk can differ between regimens, so a general label such as “chemotherapy” is not enough to choose an option.
Age and ovarian reserve also influence what egg or embryo freezing may achieve. The number of eggs available and the likely response to stimulation vary, and freezing cannot guarantee a future pregnancy. A fertility specialist can discuss what your age, test results and available time mean for you, without treating a test as a precise prediction of future success.
A 2025 systematic review by Shilpa Kalluru, Michelle Vu and Paula C. Brady emphasized that fertility-preservation choices depend on age, treatment urgency, cancer type and overall health. If there is time for stimulation, egg or embryo freezing may be considered. If treatment cannot wait, tissue freezing may be an option for some patients. If none is appropriate or available, ask about ovarian suppression and what it can—and cannot—do.
Ask For A Referral Now, Without Delaying Urgent Care
Tell your oncology team promptly if future biological children matter to you, even if you are unsure about parenthood. Ask for a referral to a reproductive specialist experienced in cancer care. The specialist and oncology team can coordinate a decision around your treatment start date. Fertility counseling should happen early, but it should not cause an unsafe delay in urgent cancer treatment.
Useful questions include: How could each planned treatment affect my ovaries? How much time do I have before treatment must start? Which options fit that window and my health? What are the likely costs, funding arrangements and storage rules where I live? Access, funding and regulations differ across countries and clinics, so ask for local details rather than assuming the same option is available everywhere.
These choices can be emotionally and medically complex. Your oncology and fertility teams can explain the options for your particular treatment plan; if a decision is time-sensitive, contact your cancer team rather than waiting for a routine appointment.